| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5639625 | The Journal of the American Dental Association | 2016 | 16 Pages |
Abstract
Pain was reduced significantly in the group that received BoTN-A compared with the placebo group at 2 to 6 months but not at 4 to 6 weeks (with moderate quality of the evidence). Additional studies with larger numbers of participants are needed to confirm these results.
Keywords
VASGrading of Recommendations, Assessment, Development and EvaluationMTrPTMDRCTTMJNSAIDRDC/TMDRandomized controlled trialRandomized controlled trialsAChTemporomandibular disordersAcetylcholinenonsteroidal anti-inflammatory drugmyofascial painBotulinum toxin type AMyofascial pain syndromeadverse eventMeta-analysisMeshResearch Diagnostic Criteria for Temporomandibular Disorderstemporomandibular jointGradevisual analog scaleMedical Subject HeadingsMyofascial trigger pointsMPs
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Mohammad DDS, MS, Kalpesh DMD, MS, Nibu DDS, MS, Piedad DDS, Reyes PhD,